Jury selection began Monday in the first bellwether case among nearly 3,000 lawsuits coordinated for pretrial purposes in 2011 before U.S. District Judge Rebecca Doherty in Lafayette, La. A bellwether case is one selected by the parties whose outcome could help resolve issues common to the litigation.
Doherty, of the Western District of Louisiana, is hearing the case against Takeda Pharmaceuticals International Inc. and Eli Lilly and Co., which jointly marketed Actos for treatment of Type II diabetes. A second bellwether trial is scheduled for April 14.
